Latest Software Platforms News

NoviqTech has agreed to sell its Carbon Central and Fuel Central assets for AUD 1 million, freeing up resources to expand its biochar carbon dioxide removal projects through Coralia.

Simble Solutions edges closer to $1 million in annual recurring revenue as major customer rollouts advance and its NanoSensor program moves forward along a structured development pathway.

Thrive Tribe Technologies (ASX:1TT) is issuing up to 1.5 billion free attaching options to recent placement participants, exercisable at $0.003 and expiring in 2029, potentially raising $4.5 million if fully exercised.

Vitrafy Life Sciences has teamed up with Vitalant Innovation Center to tackle the impending gap in red blood cell cryopreservation technology in the US, aiming to replace soon-to-be-discontinued legacy methods and potentially expand into other blood products.

Tetratherix Limited secures $15 million via institutional placement plus a capped $2 million share purchase plan at a 14% discount, aiming to fast-track manufacturing expansion and commercial partnerships.

Thrive Tribe Technologies (ASX:1TT) is fast-tracking the relaunch of its legacy HR platforms, WooBoard and REFFIND, integrating AI features to serve enterprise, government, and defense sectors managing dispersed workforces.

BCAL Diagnostics has embedded referral forms for its early cancer detection tests into clinical software used by 97% of Australian GPs, launched a telehealth platform, and opened a Sydney clinic, gearing up for a multi-cancer test launch in June 2026.

Superloop showcased sustained earnings improvement and strategic fibre network expansion, spotlighting its pending Lightning Broadband acquisition to boost FTTP scale.

4DMedical has made significant strides in commercial adoption of its CT:VQ™ lung imaging technology, securing top US hospital contracts, regulatory approvals in Europe and the UK, and a major pharmaceutical partnership, all backed by strong capital raises and inclusion in the S&P/ASX 200.

FINEOS Corporation Holdings PLC reported its strongest quarterly cash inflow ever alongside key contract wins in Australia and North America, maintaining its FY26 revenue guidance and advancing AI integration in its insurance software platform.

Locate Technologies (NZX: LOC) reported its first positive Group EBITDA quarter with NZ$167k profit, driven by a 42% revenue jump in its AI-powered Locate2u platform. The company also launched a NZ$500,000 on-market share buyback, signalling confidence in undervalued shares.

BCAL Diagnostics has expanded its Avantect cancer blood tests nationally through major pathology networks, generating $88,000 in Q3 revenue from 91 tests. The company also submitted an initial Medicare reimbursement application for pancreatic cancer detection and is preparing to launch an enhanced BREASTESTplus 2.0 test in early 2027.